Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RAS”

525 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 525 results

Not applicableStudy completedNCT01501409
What this trial is testing

Effect of Sodium Lauryl Sulfate on Recurrent Aphthous Stomatitis

Who this might be right for
Recurrent Aphthous Stomatitis
Yonsei University 90
Testing effectiveness (Phase 2)UnknownNCT02515734
What this trial is testing

FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab

Who this might be right for
Colorectal Cancer
Japan Clinical Cancer Research Organization 360
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05640726
What this trial is testing

The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy

Who this might be right for
Rectal Cancer
Fujian Cancer Hospital 30
Post-approval studies (Phase 4)Study completedNCT01049984
What this trial is testing

Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
Teva Neuroscience, Inc. 328
Post-approval studies (Phase 4)Study completedNCT01497652
What this trial is testing

A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy

Who this might be right for
Parkinson's Disease
Georgetown University 34
Early research (Phase 1)WithdrawnNCT02573220
What this trial is testing

Irinotecan Hydrochloride With FOLFIRI and Cetuximab as First-Line Therapy in Treating Patients With RAS Wild-Type Colorectal Cancer

Who this might be right for
Stage IVA Colorectal CancerStage IVB Colorectal Cancer
University of Chicago
Early research (Phase 1)Looking for participantsNCT06804824
What this trial is testing

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Vividion Therapeutics, Inc. 220
Not applicableStudy completedNCT03974490
What this trial is testing

Effect of RAS on Balance and Gait After Stroke

Who this might be right for
StrokeGait, HemiplegicGait Disorders, Neurologic
Hospital Sociosanitari Mutuam Girona 55
Post-approval studies (Phase 4)Study completedNCT00674596
What this trial is testing

The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria

Who this might be right for
DiabetesProteinuriaRenin Angiotensin System
Gulhane School of Medicine 60
Testing effectiveness (Phase 2)UnknownNCT02071069
What this trial is testing

Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer

Who this might be right for
Incurable Colorectal CancerRAS-wild-type
Tianshu Liu 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585320
What this trial is testing

A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorPancreatic AdenocarcinomaMalignant Melanoma (Cutaneous)+1 more
Immuneering Corporation 209
Testing effectiveness (Phase 2)Active Not RecruitingNCT05312398
What this trial is testing

CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen

Who this might be right for
Metastatic Colorectal Adenocarcinoma
University of Campania Luigi Vanvitelli 219
Large-scale testing (Phase 3)Study completedNCT00203164
What this trial is testing

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 254
Testing effectiveness (Phase 2)UnknownNCT00964457
What this trial is testing

Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients

Who this might be right for
Rectum Cancer
Copenhagen University Hospital at Herlev 60
Early research (Phase 1)Study completedNCT01652313
What this trial is testing

Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women

Who this might be right for
Parkinson's Disease
H. Lundbeck A/S 12
Large-scale testing (Phase 3)UnknownNCT04262635
What this trial is testing

Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 80
Large-scale testing (Phase 3)Study completedNCT00640471
What this trial is testing

Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
NCIC Clinical Trials Group 750
Not applicableStudy completedNCT01822444
What this trial is testing

ANGIOPREDICT. ICORG 12-16, V3

Who this might be right for
Advanced Colorectal Cancer
Cancer Trials Ireland 76
Large-scale testing (Phase 3)Study completedNCT00203034
What this trial is testing

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

Who this might be right for
Parkinson's Disease
Teva Branded Pharmaceutical Products R&D, Inc. 472
Not applicableUnknownNCT05051592
What this trial is testing

Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
National University Hospital, Singapore 40
Load More Results